Dr. Christopher Decker, MD

NPI: 1679734933
Total Payments
$7,149
2024 Payments
$848.24
Companies
39
Transactions
442
Medicare Patients
6,242
Medicare Billing
$632,157

Payment Breakdown by Category

Food & Beverage$6,427 (89.9%)
Travel$521.41 (7.3%)
Other$200.00 (2.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,427 439 89.9%
Travel and Lodging $521.41 2 7.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $200.00 1 2.8%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,640 138 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $994.14 73 $0 (2024)
Boston Scientific Corporation $895.28 14 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $452.25 30 $0 (2023)
GENZYME CORPORATION $440.34 17 $0 (2024)
Celgene Corporation $282.38 23 $0 (2024)
PFIZER INC. $217.85 18 $0 (2024)
Shire North American Group Inc $211.69 2 $0 (2018)
INTERCEPT PHARMACEUTICALS, INC. $172.60 11 $0 (2022)
Gilead Sciences, Inc. $165.29 10 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $848.24 48 GENZYME CORPORATION ($237.12)
2023 $801.99 53 AbbVie Inc. ($212.49)
2022 $1,185 85 ABBVIE INC. ($328.17)
2021 $1,175 80 AbbVie Inc. ($341.98)
2020 $410.14 30 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($163.43)
2019 $698.96 52 Takeda Pharmaceuticals U.S.A., Inc. ($180.29)
2018 $1,321 41 Boston Scientific Corporation ($685.88)
2017 $709.03 53 Allergan Inc. ($149.73)

All Payment Transactions

442 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/12/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $18.65 General
Category: Rare Disease
12/09/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $27.02 General
Category: GASTROENTEROLOGY
11/21/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $21.66 General
Category: THERAPY FOR CSID
11/19/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $14.06 General
Category: Immunology
11/14/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $104.25 General
Category: Immunology
11/12/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $30.23 General
Category: Immunology
11/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $9.61 General
Category: IMMUNOLOGY
11/04/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $20.23 General
Category: LIVER DISEASE
10/24/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $19.03 General
Category: GASTROENTEROLOGY
10/19/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $12.97 General
Category: VIROLOGY
10/17/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $16.31 General
Category: Immunology
10/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $9.56 General
Category: IMMUNOLOGY
10/04/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $21.76 General
Category: GI
09/18/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $15.82 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/13/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $18.11 General
Category: Rare Disease
09/09/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.38 General
Category: IMMUNOLOGY
09/05/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $23.22 General
Category: THERAPY FOR CSID
08/29/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $13.33 General
Category: Immunology
08/27/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $10.96 General
Category: IMMUNOLOGY
08/23/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $18.33 General
Category: Rare Disease
08/22/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.22 General
Category: Neuroscience
08/15/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $10.84 General
Category: IMMUNOLOGY
07/24/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.09 General
Category: GASTROENTEROLOGY
07/23/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $3.00 General
Category: IMMUNOLOGY
07/22/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN, PLENVU Food and Beverage In-kind items and services $14.24 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 1,080 1,154 $575,955 $113,657
2022 26 1,340 5,619 $820,705 $201,358
2021 27 1,798 1,993 $746,164 $149,367
2020 29 2,024 2,279 $828,774 $167,774
Total Patients
6,242
Total Services
11,045
Medicare Billing
$632,157
Procedure Codes
102

All Medicare Procedures & Services

102 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 98 98 $110,250 $19,187 17.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 118 137 $20,550 $11,063 53.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 139 156 $16,380 $8,699 53.1%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 50 50 $44,750 $8,344 18.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 65 66 $64,680 $7,797 12.1%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 97 98 $78,400 $7,646 9.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 60 60 $13,800 $6,618 48.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 87 87 $13,050 $6,229 47.7%
43274 Insertion of stent into pancreatic or bile duct using a flexible endoscope Facility 2023 16 17 $22,475 $5,600 24.9%
43264 Removal of stone or debris from bile or pancreatic duct using a flexible endoscope Facility 2023 24 26 $31,200 $4,866 15.6%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 58 59 $34,220 $4,859 14.2%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 26 27 $24,165 $4,243 17.6%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 31 32 $28,640 $3,816 13.3%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 58 58 $8,410 $3,643 43.3%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 22 32 $19,520 $3,111 15.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 31 31 $6,045 $3,060 50.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 34 41 $4,510 $2,463 54.6%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 37 50 $3,500 $1,884 53.8%
43262 Incision of pancreatic outlet using a flexible endoscope Facility 2023 13 13 $15,730 $336.83 2.1%
45381 Injection beneath lining of large bowel using a flexible endoscope Facility 2023 16 16 $15,680 $192.72 1.2%
J3380 Injection, vedolizumab, 1 mg Office 2022 12 4,200 $176,400 $68,907 39.1%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 123 124 $139,500 $23,290 16.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 139 162 $24,300 $14,018 57.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 131 133 $106,400 $11,585 10.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 75 75 $17,250 $8,849 51.3%

About Dr. Christopher Decker, MD

Dr. Christopher Decker, MD is a Gastroenterology healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1679734933.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Decker, MD has received a total of $7,149 in payments from pharmaceutical and medical device companies, with $848.24 received in 2024. These payments were reported across 442 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,427).

As a Medicare-enrolled provider, Decker has provided services to 6,242 Medicare beneficiaries, totaling 11,045 services with total Medicare billing of $632,157. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Tupelo, MS
  • Active Since 06/19/2008
  • Last Updated 03/06/2025
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1679734933

Products in Payments

  • XIFAXAN (Drug) $696.60
  • DUPIXENT (Biological) $440.34
  • SPYGLASS (Device) $404.40
  • HUMIRA (Biological) $378.11
  • ZEPOSIA (Drug) $350.96
  • LINZESS (Drug) $325.62
  • GENERAL BILIARY DEVICES (Device) $293.67
  • TRULANCE (Drug) $268.21
  • Humira (Biological) $256.88
  • RINVOQ (Biological) $254.82
  • Entyvio (Biological) $205.95
  • XELJANZ (Drug) $204.61
  • ENTYVIO (Biological) $190.41
  • Cimzia (Drug) $161.73
  • OCALIVA (Drug) $143.32
  • MAVYRET (Drug) $141.20
  • Creon (Drug) $139.99
  • DIFICID (Drug) $120.27
  • CREON (Drug) $115.40
  • Linzess (Drug) $114.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Tupelo